Tamás Masszi
- Hematology top 0.1%
- Oncology top 1%
- Genetics top 0.2%
- Molecular Biology top 5%
- Pathology and Forensic Medicine top 1%
- Co-authors
- Ivan ŠpıčkaAntonio PalumboMaría‐Victoria MateosWilliam DeraedtAndrew SpencerKatja WeiselTomer M. MarkPieter Sonneveld
- Topics
- Multiple Myeloma Research and Treatments (65 papers)Chronic Myeloid Leukemia Treatments (42 papers)Chronic Lymphocytic Leukemia Research (31 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- HungaryUnited StatesItaly
In The Last Decade
Tamás Masszi
179 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Hematology 3.8k
- Oncology 2.3k
- Genetics 2.3k
- Molecular Biology 2.3k
- Pathology and Forensic Medicine 1.1k
Countries citing papers authored by Tamás Masszi
This map shows the geographic impact of Tamás Masszi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamás Masszi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamás Masszi more than expected).
Fields of papers citing papers by Tamás Masszi
This network shows the impact of papers produced by Tamás Masszi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamás Masszi. The network helps show where Tamás Masszi may publish in the future.
Co-authorship network of co-authors of Tamás Masszi
This figure shows the co-authorship network connecting the top 25 collaborators of Tamás Masszi. A scholar is included among the top collaborators of Tamás Masszi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamás Masszi. Tamás Masszi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 6 | |
| 7 | 47 | |
| 8 | 2 | |
| 9 | 28 | |
| 10 | 5 | |
| 11 | 1 | |
| 12 | 5 | |
| 13 | Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Studybreakdown → | 386 |
| 14 | 58 | |
| 15 | 7 | |
| 16 | 7 | |
| 17 | 23 | |
| 18 | 48 | |
| 19 | 19 | |
| 20 | 111 |
About Tamás Masszi
Tamás Masszi is a scholar working on Hematology, Genetics and Oncology, having authored 188 papers that have together received 6.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (65 papers), Chronic Myeloid Leukemia Treatments (42 papers) and Chronic Lymphocytic Leukemia Research (31 papers). The work is most often cited by research in Hematology (3.8k citations), Genetics (2.3k citations) and Oncology (2.3k citations). Tamás Masszi has collaborated with scholars based in Hungary, United States and Italy. Frequent co-authors include Ivan Špıčka, Antonio Palumbo, María‐Victoria Mateos, William Deraedt, Andrew Spencer, Katja Weisel, Tomer M. Mark, Pieter Sonneveld, Ajay K. Nooka and Xiang Qin. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.